Jan 29 (Reuters) - Biocon Ltd:
* MYLAN AND BIOCON RECEIVE POSITIVE CHMP OPINION FOR SEMGLEEâ„¢, BIOSIMILAR INSULIN GLARGINE
* MYLAN NV - CHMP POSITIVE OPINION WILL BE CONSIDERED BY EUROPEAN COMMISSION
* MYLAN NV - EUROPEAN COMMISSION DECISION ON APPROVAL IS EXPECTED IN APRIL
* MYLAN NV - EUROPEAN COMMISSION DECISION ON APPROVAL IS EXPECTED IN APRIL
* MYLAN - IN ADDITION TO EUROPEAN SUBMISSION, MARKETING APPLICATIONS FOR SEMGLEE BEEN SUBMITTED IN AUSTRALIA, CANADA, U.S. & PLANNED FOR KEY EMERGING MARKETS Source text for Eikon: Further company coverage:
 